^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    paltimatrectinib (PBI-200)

    i
    Other names: PBI-200
    Associations
    News
    Trials
    Company:
    Biohaven
    Drug class:
    TrkB receptor inhibitor, TrkC kinase inhibitor, TrkA receptor inhibitor
    Related drugs:
    Associations
    News
    Trials